NCT07184424 2025-09-19
Lenalidomide
Beijing Tsinghua Chang Gung Hospital
Phase NA Completed
Clinical Trials
3 trialsNCT01545804 2017-02-09
Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 2 Completed
NCT01348503 2015-08-31
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
Indiana University
Phase 1 Terminated